AlphAIAlphAI — Financial news for AI agents
investing.com$CLBT

Cellebrite earnings beat by $0.07, revenue fell short of estimates

Cellebrite (CLBT) reported Q3 EPS of $0.17, beating estimates by $0.07, but revenue of $149M missed expectations of $150.3M. The stock is up 14% over 3 months but down 34% over 12 months. InvestingPro rates its financial health as 'great performance'.

Original reporting
investing.com
Published Nov 12, 2026, 12:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 12:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CLBT
Bullish
high confidence
Mentioned
$CLBT
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CLBTBullishHigh
01

Why it matters

The earnings beat provides a fresh catalyst for short‑term price movement, while the slight revenue shortfall may limit upside.

02

Market read

Earnings surprise for a micro‑cap could trigger volatility and trading opportunities.

03

What to watch

Potential upcoming contract wins or regulatory changes could offset revenue concerns.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

Cellebrite is a provider of digital intelligence solutions, listed on NASDAQ under CLBT.

Company-level read

Ticker impact

$CLBTBullishHigh confidence
Context

Cellebrite reported Q3 EPS of $0.170, beating estimates by $0.07, while revenue was $149M versus $150.3M consensus.

Expected impact

likely upward pressure as traders price in the earnings beat

Evidence & confidence

The surprise EPS beat is a fresh, material data point for a micro‑cap, prompting immediate market reaction.

Market effects

Sector

Limited to digital forensics and security software niche; modest peer impact.

Regional

U.S. tech micro‑cap segment may see slight ripple.

Global

Low; company is niche with limited global exposure.

Counterpoint

What could challenge this read

Revenue miss could signal slowing demand, suggesting caution despite EPS beat.

Key entities

  • company
    Cellebrite

    Digital intelligence and forensics firm reporting Q3 results.

Read at source← All news

Also covered by

1 outlet

Related articles

$CLBTHighAI 8/10

Cellebrite DI Ltd. (CLBT): Financial results for Q3 2026

Cellebrite DI Ltd. (CLBT) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Cellebrite Reports Third-Quarter 2026 Results Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, VA and

SEC EDGAR 6-K
$CLBTHigh

Cellebrite Reports Third-Quarter 2026 Results

Cellebrite reported Q3 2026 results with ARR up 20% to $528.5M, revenue up 18% to $149M, and adjusted EBITDA of $53.6M. CEO Shiv Ramji highlighted strong international and U.S. Federal performance, and raised 2026 adjusted EBITDA outlook to $163M-$166M. The company also announced plans to redomicile in the U.S. and progress with its Genesis AI solution.

prnewswire.com
$CLBTMedAI 8/10

Cellebrite (CLBT) Q2 2026 Earnings Call Transcript

Cellebrite (CLBT) announced Shiv Ramji as its new CEO, replacing Tom Hogan. The company missed Q2 revenue expectations due to delayed large transactions and lower-than-expected ARR uplift. Despite this, they raised their full-year adjusted EBITDA target. Ramji outlined plans to improve sales execution and forecasting discipline. The company sees growth in new products and federal business, with a 25% increase in Defense and Intelligence ARR.

yahoo.com
$CLBTMedAI 8/10

Why Cellebrite DI (CLBT) Is Down 30.4% After Cutting 2026 Outlook And Announcing CEO Transition

Cellebrite DI Ltd. reported half-year 2026 results and cut its full-year revenue outlook to US$555 million to US$561 million, implying 17% to 18% growth. The company also announced a CEO transition, with Shiven Ramji succeeding Thomas E. Hogan. The guidance reduction, weaker profitability, and delayed large government contracts contributed to a sharp stock drop.

simplywall.st